德国勃林格殷格翰的思力华怎么购买？

The generic name of (Respimat) is cetiobromide dry powder inhalation. Cetiobromide is a bronchodilator and is suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the maintenance treatment of accompanying dyspnea and the prevention and treatment of acute exacerbations. Sliva was launched globally in 2002. Sliva was launched in China in 2006, and the Respimat device was launched globally the next year. In these listed countries and regions, patients can buy Spiriva from Boehringer Ingelheim of Germany.

Spiriva of Germany's Boehringer Ingelheim has been on the market in China for 14 years. It has been included in the national medical insurance catalog and is a Class B drug. Patients can rely on medical insurance to reimburse some drugs when purchasing drugs. In addition, patients can also choose to purchase drugs overseas and choose a more cost-effective drug. It is understood that the current price of Silihua can be as low as 170$ per box. Patients in need can contact Medical Companion Travel to obtain their specific drug purchasing channels. Of course, if financial conditions permit, patients can also go abroad to purchase medicines on their own.

Boehringer Ingelheim is a leading pharmaceutical company highly driven by research and development, ranking among the top 20 in the world. Its core businesses include prescription drugs, animal health and biopharmaceuticals, with its business scope covering all major provinces, cities and regions across the country. Patients can use the drugs it develops with confidence.

The main ingredient of one of the products of Boehringer Ingelheim in Germany is tiotropium bromide, which has an affinity similar to the muscarinic receptor subtype MI-M5. It can bind to the M3 receptor on smooth muscle, block the efferent branches of the postganglionic vagus nerve, relax the smooth muscle to achieve the purpose of dilating the bronchus, and can also reduce the bronchial airway inflammatory response and delay the further development of lung function. The drug is currently on the market in many countries and regions around the world, and patients in need can selectively purchase the drug based on their actual needs.

Recommended hot articles: /newsDetail/92298.html